Home
NICE Guidance
Conditions and diseases
Cardiovascular conditions
Lipid disorders
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
Technology appraisal guidance [TA393]
Published:
22 June 2016
Guidance
Tools and resources
Information for the public
Evidence
History
Do no do examples
Do no do examples for Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
Title
Year published
Impact Level
No results could be found